Search

Your search keyword '"Navarro-Zapata A"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Navarro-Zapata A" Remove constraint Author: "Navarro-Zapata A"
87 results on '"Navarro-Zapata A"'

Search Results

2. Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations

3. Inherited human ezrin deficiency impairs adaptive immunity

4. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells

6. Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells

8. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells

9. Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release

10. SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

11. Technological intensity in manufacturing trade between ASEAN and the EU: challenges and opportunities

12. Drivers of technological export performance in Spain: A regional approach, 2000-2016.

13. A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia

15. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and n vivo but fail to eliminate leukemiai nitiating cells

16. DataSheet_1_NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells.pdf [Dataset]

17. Determinants of High-tech Exports: New Evidence from OECD Countries

18. Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells

19. Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release

20. Donor selection for adoptive cell therapy with CD45RA

21. P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.

22. Donor’s graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental study

24. Evolución de la intensidad tecnológica y ventajas comparativas de las exportaciones de manufacturas españolas durante el periodo 2000-2018

25. A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia

26. A Mathematical Description of the Bone Marrow Dynamics of CAR T-Cell Therapy in B-cell Childhood Acute Lymphoblastic Leukemia

29. Optimizing the procedure to manufacture clinical‐grade NK cells for adoptive immunotherapy

30. A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia

31. A Mathematical Description of the Bone Marrow Dynamics of CAR T-Cell Therapy in B-cell Childhood Acute Lymphoblastic Leukemia

32. Expression of infiltrating bone marrow natural killer cell receptors in pediatric acute leukemia

33. Estudio fenotípico de células NK infiltradas en médula ósea (BiNK) en pacientes pediátricos con leucemia aguda

34. A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia

35. SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

36. Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy

37. A phase II clinical trial of infusing haploidentical K562-mb-IL15-41BBL activated and expanded Natural Killer cells as consolidation therapy for pediatric acute myeloblastic leukemia

40. El aprendizaje basado en retos como agente generador de ideas transformadoras en el mundo empresarial

41. Supporting Israel by withholding support to International Organizations: UNRWA and UNESCO in Trump’s foreign policy

42. Me mareo cuando me peinas

44. SARS-CoV-2 specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking and large-scale production for Adoptive Cell Therapy

45. Donor’s graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental study

47. Estudios sobre la intensidad tecnológica de las exportaciones de manufacturas : análisis general y del caso España-Asia

48. Doctor@, necesito una masterclass para alimentar a mi bebé

49. Mi niño cojea: ¿debo preocuparme?

Catalog

Books, media, physical & digital resources